Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs

 In the final chapter of disgraced gut testing player uBiome’s story, Psomagen has acquired all its key assets in a fire sale, including 246 microbiome patents, anonymized data, nearly 300,000 samples and equipment from uBiome’s lab in San Francisco.